InvestorInvesting in private markets for over 30 years.

Kurma Partners is a Paris-based venture capital firm specializing in healthcare and biotechnology investments across Europe. They manage approximately €890 million and focus on supporting early-stage companies and collaborating with research centers.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Kurma Partners is an investment firm founded in 2009 and based in Paris, France. The organization focuses on funding healthcare and biotechnology companies in Europe, investing at various stages of maturity, from company creation to capital expansion. With a strong emphasis on collaboration with leading European research centers, Kurma Partners aims to develop innovative medical solutions. They manage approximately €890 million and have financed over 72 companies since their inception, employing a strategy that includes investments in biotherapies, diagnostics, and deep tech.
Kurma Partners primarily invests in the healthcare and biotechnology sectors, employing a strategy that encompasses various stages of company maturity. Their focus includes biotherapies, diagnostics, and deep tech, allowing them to support a diverse range of innovative solutions in the life sciences.
Kurma Partners adds value to its portfolio companies by leveraging its extensive network and expertise in the healthcare and biotechnology sectors. The firm collaborates closely with its companies, providing strategic guidance and access to leading research institutions to accelerate innovation and growth.
Kurma Partners invests primarily in early-stage healthcare and biotechnology companies. They focus on sectors such as biotherapies, diagnostics, and deep tech, and prefer to engage with companies at various stages from pre-seed to growth equity.
Startups can reach out to Kurma Partners via email at contact@kurmapartners.com. It is advisable to include a detailed pitch deck that outlines the business model, market opportunity, and team background.
Kurma Partners distinguishes itself through its strong collaboration with leading European research centers, which enhances its ability to support innovative medical solutions. Their focus on healthcare and biotechnology allows them to provide specialized guidance and resources to portfolio companies.
Kurma Partners primarily invests in Europe, focusing on healthcare and biotechnology sectors within this region.
While specific check sizes are not disclosed, Kurma Partners invests across various stages, indicating a flexible approach to funding that can accommodate different capital needs.
Kurma Partners actively collaborates with its portfolio companies, providing strategic guidance and access to its extensive network within the healthcare and biotechnology sectors to accelerate growth and innovation.
Superscout Pro
Is this page right?Reviewed · How the research works